General
Johnson & Johnson COVID-19 vaccine under review by European Medicines Agency over blood clots
Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.
Key points:
- Johnson & Johnson said it was aware of the rare reports of blood clots, and was working with regulators to assess the data
- The US Food and Drug Administration said it was aware of the reports, but they had “not found a causal relationship with vaccination”
- It follows an investigation of blood clots reported by some people given the AstraZeneca vaccine, which has prompted some countries to change their vaccine recommendations
The European Medicines Agency’s safety committee has also been looking at how AstraZeneca’s COVID-19 vaccine is associated with very rare cases of…
Continue Reading
-
Business13 hours agoWhere I’d invest $5,000 into ASX dividend shares right now
-
Noosa News23 hours agoMan charged after hundreds of illegal firearm parts imported from US busted at border
-
Business10 hours ago$20,000 in savings? Here’s how to target $1,000 of passive income each month
-
General17 hours agoUK police drop Kneecap investigation over Glastonbury set